Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Peter Netland, MD
With
New World Medical, Inc.
The purpose of this study is to evaluate and compare the clinical outcomes after implantation of the porous plate (polyethylene) (Model M4) Ahmed Glaucoma Valve with the silicone plate Ahmed Glaucoma Valve (Model FP7) in participants with refractory glaucoma. Participation will last for 12 months.
Age
18–80
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Male or female of any race ≥ 18 years and ≤ 80 years of age.
Diagnosis of intractable glaucoma in the study eye, with the exception of silicone oil endotamponade induced glaucoma, which has not responded to conventional medical and surgical therapy.
Elevated intraocular pressure \> 21 mmHg in the study eye. Two consecutive measurements using Goldmann Applanation Tonometry will be obtained and the mean of those two measurements will be considered the subject's baseline intraocular pressure.
Subject is a candidate for surgery in the study eye with a glaucoma drainage device.
Subject is willing and able to sign the informed consent.
You may not be if
Diagnosis of silicone oil endotamponade induced glaucoma in the study eye.
History of prior drainage implant surgery in the study eye.
History of cyclophotocoagulation of the study eye.
